Fully human therapeutic antibodies specific for human CD38

作者: Michael Tesar , Ute Jäger

DOI:

关键词:

摘要: The present invention nucleic acids encoding novel antibodies and functional fragments thereof specific for CD38. Such are useful the treatment of diseases associated with CD38 expression, including hematological malignancies such as multiple myeloma.

参考文章(64)
Detlef Güssow, Gerhard Seemann, Humanization of monoclonal antibodies. Methods in Enzymology. ,vol. 203, pp. 99- 121 ,(1991) , 10.1016/0076-6879(91)03007-4
I. Kukimoto, Fabio Malavasi, K. Kontani, S. Hoshino, T. Katada, S. Inoue, Y. Kanda, Mapping of the catalytic and epitopic sites of human CD38/NAD+ glycohydrolase to a functional domain in the carboxyl terminus. Journal of Immunology. ,vol. 158, pp. 741- 747 ,(1997)
Santiago Partida-Sanchez, Troy D. Randall, Frances E. Lund, CD38 modulated chemotaxis ,(2001)
F Malavasi, G C Spagnoli, A Funaro, S Roggero, M Alessio, D Delia, C M Ausiello, M Zaccolo, Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. Journal of Immunology. ,vol. 145, pp. 2390- 2396 ,(1990)
Clark Pan, Claudia Hirth-Dietrich, Andreas M. Knorr, Michael Schauer, Sabine Kraft, Barbara Krebs, Human TIMP-1 antibodies ,(2002)
Tomonori Tawara, Shiro Kataoka, Anti-hla-dr antibody ,(2002)
Roberto De Pascalis, Makoto Iwahashi, Midori Tamura, Eduardo A. Padlan, Noreen R. Gonzales, Ameurfina D. Santos, Mariateresa Giuliano, Peter Schuck, Jeffrey Schlom, Syed V. S. Kashmiri, Grafting of “Abbreviated” Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody The Journal of Immunology. ,vol. 169, pp. 3076- 3084 ,(2002) , 10.4049/JIMMUNOL.169.6.3076
A Tutt, M J Glennie, J H Ellis, G T Stevenson, K A Barber, C Hale, A P Lewis, J S Crowe, Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma. Journal of Immunology. ,vol. 155, pp. 925- 937 ,(1995)